
How T3 scaled faster in Basel’s biotech labs
T3 Pharmaceuticals shows how a biotech can move from first experiments to a major international deal keeping pace - and roots - in the Basel Area. The team built, tested and scaled inside Switzerland Innovation Park Basel Area’s Main Campus. Flexible private labs, certified shared facilities and an on-site expert community cut friction at every step. The result: faster iteration, smarter use of capital and a clear path from seed to global relevance — all inside Europe’s densest life sciences cluster.
T3 started with a precise idea and a small team. Early experiments ran within the Basel Area ecosystem. When it was time to scale, they chose the newly built Main Campus. The team moved into a private wet lab, plugged into a curated peer community and generated data fast. As needs grew, they expanded within the same building – into a fully fitted, flexible lab space that was available right away. No long buildouts. No idle square meters. Just steady progress matched to milestones.
Why the lab model mattered
Drug discovery doesn’t run in straight lines. It surges, pauses and pivots. Being at Main Campus lets you ride those waves. When your needs expand, you scale up without a full relocation. T3 used this to keep momentum through proof of concept, entering the clinical phase and partnering.
Speed from proximity
Being in Basel puts you close to partners, suppliers and talent. You’re minutes from pharma leaders, CROs and the University of Basel network. That proximity shortens cycles – especially when peers share practical know-how and hard-won experience, swap materials fast or help you find a specialist hire. For T3, the neighborhood wasn’t a backdrop. It was part of an operating model built for speed.
Focus on experiments, not logistics
An on-site expert community and lab teams keep admin light. You get access badges, safety briefings and waste handling without losing a week to admin. Events, the curated community and resident services reduce overhead and open doors. It’s easier to focus on experiments, not logistics.
Designed for leaders who think ahead
If you run a biotech with a sharp roadmap, you need a lab that moves as fast as your learning curve. Main Campus gives you the mix that matters: customizable or move-in-ready private labs, certified shared capacity, an on-site expert community and a dense peer network. It’s a practical, low-friction path with suitable options for every stage, from spin-offs and first labs to scale-ups and global headquarters.
See how T3 did it
Explore the full T3 story and how Switzerland Innovation Park Basel Area’s Main Campus helped them scale with speed and flexibility.
Read the full story about T3 and learn more about Main Campus!



Adobe stock photos - https://european-biotechnology.com/latest-news/roche-moves-obesity-asset-ct-388-into-phase-iii/
X-act Cologne Clinical Research GmbH
NATO